Welcome : Guest

Essex Bio-Technology Ltd. (Hong Kong) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Essex Bio-Technology Ltd., which is principally involved in Developing Biopharmaceutical Products. Illustrated with 107 tables, the report showcases the company's sales performance, key markets and market position as against its competitors operating in the industry.

Code: PCP-34380
Price: $3500
Company Type: Public
Pages: 109
Date: January 2017
Market Data Tables: 107

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Table 1: Essex Bio-Technology Ltd.'s Sales by Product Segment (2014-2015) in Percentage for Pharmaceutical Products, and Provision of Marketing Services......3
Biopharmaceuticals......4
Table 2: Biopharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Norditropin, NovoSeven, Turoctocog Alpha, and Others......4
Drugs......5
Table 3: Drugs Market by Region Worldwide (2015) - Percentage share Breakdown by Value Sales for Switzerland, US, Others Europe, and Rest of World......5
Table 4: Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Specialty Drugs, and Traditional Oral Drugs......6
Table 5: Spending on Drugs by Region Worldwide (2015) - Percentage Market Share Breakdown by Value for Canada, European Union, Japan, South Korea, US, and Others......7
Table 6: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics, Monoclonal Antibodies and Other Classes......8
Table 7: Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Brand, Generic and Others......9
Table 8: Drugs Market by Technology Worldwide (2015) - Percentage Share Breakdown by Value for Biotechnology, Conventional and Other Unclassified......10
Table 9: Spending on Medicines by Region Worldwide (2015) - Percentage Share Breakdown by Value for Asia, Australia, Europe, Latin America, North America, and others......11
Table 10: Drug Market by Category in Asia-Pacific (2015) - Percentage Share Breakdown by Value Sales for Branded Generics, Originals and Un-Branded Generics......12
Table 11: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Sales for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......13
Table 12: Government Spending on Drugs by Category in Australia (2015) - Percentage Market Share Breakdown by Volume for Acid Blockers, Analgesics, Anti-Cancer, Anti-Diabetes, Antihypertensives, Anti-Lipids, Anti-Obstructive Airway Disease, Immunosuppress, Ophthalmologicals, Psychoanaleptics, Psycholeptics, and Others......14
Table 13: Drugs Market by Category in Brazil (2015) - Percentage Share Breakdown by Volume for Generics and Others......15
Table 14: Drug Distribution Expenditure by Category in Canada (2015) - Percentage Share Breakdown by Value for Out of Pocket, Private Insurers and Public Payers......16
Table 15: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Medical Devices, Over-the-counter Drugs, Prescription Drugs, Traditional Chinese Medicine, and Others......17
Table 16: Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Finished Drugs and Intermediate and Bulk Medicine......18
Table 17: Hospital Drug Market by Segment in China (2015) - Percentage Share Breakdown by Value for Anti-Infection, Cardio-Cerebral Vascular, Digest, Neurology, Oncology and Others......19
Table 18: Finished Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Antihypertensive Drugs, Digestive System Drugs, Liver Drugs and Others......20
Table 19: Patent Medicines Sales by Drugs in China (2015) - Percentage Share Breakdown by Value for Cardio-Cerebrovascular Drugs, Digestive System Drugs, Drugs for Deoplastic Diseases, Gynecological Drugs, Musculoskeletal Drugs, Nervous System Drugs, Respiratory System Drugs, Urinary System Drugs and Others......21
Table 20: Drugs Market by Category in France (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......22
Table 21: Formulations Sales by Category in India (2015) - Percentage Market Share Breakdown by Value for Anti Infective, Anti-diabetic, Central Nervous System (CNS), Cyclic Vomiting Syndrome (CVS), Gastrointestinal, Pain Management, and Others......23
Table 22: Drugs Market by Sector in Greece (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......24
Table 23: Ethical Drugs Revenues by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generic, Licensed and Unbranded Generic......25
Table 24: Drugs Market by Category in Italy (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......26
Table 25: Drugs Market by Category in Singapore (2015) - Percentage Share Breakdown by Value for Generic Drugs, OTC Drugs, and Patented Drugs......27
Table 26: Prescription Drugs Market in the US (2014) in US$ Million......28
Table 27: Critical Shortage Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Injectable, Orals, and Others......29
Table 28: Critical Shortage Drugs Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Anti-Infectives, Central Nervous System (CNS), Oncology, Pain, Vitamins and Minerals, and Others......30
Table 29: Critical Shortage Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Brand, Branded Generic, Generic, and Other Branded Generic......31
Table 30: Spending on Drugs by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Drugs and Traditional Drugs......32
Table 31: Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for Non-specialty and Specialty......33
Table 32: Drugs Sales by Type in the US (2015) - Percentage Share Breakdown by Value for Cefdinir, Cephalexin, Cofactor and Others......34
Table 33: A-2 Drugs Market by Type in the US (2015) - Percentage Share Breakdown by Value for Generic Doxycycline, Generic Minocycline, Generic Tetracycline, and Others......35
Table 34: Spending on Medicines by Category in the US (2015) - Percentage Share Breakdown by Value for Specialty Pharmaceuticals and Traditional Pharmaceuticals......36
Table 35: Spending on Medicines by Product in the US (2015) - Percentage Share Breakdown by Value for Injectable, Oral and Other Forms......37
Table 36: Spending on Medicines by Segment in the US (2015) - Percentage Share Breakdown by Value for Biologics and Small-Molecules......38
Table 37: Spending on Medicines by Source in the US (2015) - Percentage Share Breakdown by Value for Non-Retail and Retail......39
Table 38: Spending on Medicines by Type in the US (2015) - Percentage Share Breakdown by Value for Branded Generics, Brands and Unbranded Generics......40
Drugs of Abuse Testing (DOA) Testing......41
Table 39: Drugs of Abuse Testing (DOA) Testing by Technology Worldwide (2015) - Percentage Market Share Breakdown by Value for Heterogeneous, Homogenous, and POC/Rapid......41
Pharmaceuticals......42
Table 40: Pharma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Injectables, Oral Solids, Tropicals and Others......42
Table 41: Pharmaceutical Market by Country Worldwide (2015) - Percentage Share Breakdown by Value for China, Japan, USA and Others......43
Table 42: Pharmaceuticals Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia, Africa, and Australasia, European Union, Japan, Latin America, and North America......44
Table 43: Pharmaceuticals Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Generic, Originator Brand, and Others......45
Table 44: Pharmaceuticals Sales by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Active Pharmaceutical Ingredients, Contrast Products, Radiopharmaceuticals, and Specialty Pharmaceuticals......46
Table 45: Pharmaceuticals Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Biologics and Chemical Synthetic and Others......47
Table 46: New Pharmaceutical Licensed Drugs Market by Indication Worldwide (2015) - Percentage Share Breakdown by Value Sales for AIDS, Diabetes, Diabetes (DPP4), Hepatitis B, Hypertension, and Others......48
Table 47: New Pharmaceutical Licensed Drugs Market by Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Humulin, Trajenta, Truvada, Twynsta, Viread, and Others......49
Table 48: Emerging Market Pharma Sales by Country Worldwide (2015) - Percentage Share Breakdown by Value Sales for Africa & Middle East, Brazil, China, India, Russia, and Others......50
Table 49: Research & Development Spending in Pharmaceuticals by Category Worldwide (2015) - Percentage Market Share Breakdown by Value for Approval, Discovery, Pre-Clinical, Phase I, Phase II, Phase III, Phase IV, and Others......51
Table 50: Pharmaceutical Consumption by Category in Australia (2015) - Percentage Share Breakdown for Aged over 65 Years, and Aged under 65 Years......52
Table 51: Pharmaceutical Market by Region in Brazil (2015) - Percentage Share Breakdown by Value Sales for Mid-West, North, Northeast, São Paulo, South, and Others......53
Table 52: Pharmaceutical Sales by Category in Brazil (2015) - Percentage Share Breakdown by Value for Generics, Over the Counter (OTC) Drugs, and Prescription......54
Table 53: Pharmaceutical Market by Category in Canada (2015) - Percentage Share Breakdown by Value for Hospital and Retail......55
Table 54: Pharmaceutical Distribution Market by Region in China (2015) - Percentage Share Breakdown by Value for Eastern China, North East China, Northern China, Northwestern China, Southern China, and Southwestern China......56
Table 55: Pharmaceuticals Market by Therapeutic Area in China (2015) - Percentage Share Breakdown by Value Sales for Alimentary Tract and Metabolism, Blood and Blood Forming Organs, Cardiovascular Diseases, Musculo-Skeletal System, Nervous System, Oncology, Respiratory System, Systemic Anti-Infective, and Others......57
Table 56: Pharmaceutical Market by Country in Europe (2015) - Percentage Share Breakdown by Value Sales for France, Germany, Greece, Italy, Spain, UK, and Others......58
Table 57: Pharmaceutical Drugs Market by Category in Germany (2015) - Percentage Share Breakdown by Value Sales for Biopharmaceuticals, Pharma Drugs for Human Use, and Others......59
Table 58: Pharma Market by Category in Indonesia (2015) - Percentage Share Breakdown by Value for Branded Generics and Licensed, Over the Counter and Unbranded Generics......60
Table 59: Pharmaceutical Market by Region in Latin America (2015) - Percentage Share Breakdown by Value for Argentina, Brazil, Mexico, Venezuela and Others......61
Table 60: Retail Pharmaceutical Market by Type in Mexico (2015) - Percentage Share Breakdown by Value for Private Market and Public Market......62
Table 61: Spending on Pharmaceutical by Category in Nigeria (2015) - Percentage Share Breakdown by Value for Generic Drug Sales, Over-The-Counter Medicine Sales and Patented Drug Sales......63
Table 62: Private Pharmaceuticals Market by Segment in South Africa (2015) - Percentage Share Breakdown by Value for Branded and Ethical, Generic, Over the Counter and Others......64
Table 63: Pharmaceutical Drugs Manufacturers by Product Segment in the US (2015) - Percentage Share Breakdown by Value for Biological Products, Medicinal and Botanical Products, Oncological Products, and Others......65
Table 64: Speciality Pharmaceuticals Market by Category in the US (2015) - Percentage Share Breakdown by Value Sales for Anti-Coagulant, Growth Hormone, Hepatitis C, HIV/AIDS (incl oral solids), IVIG/Hemophilia, Macular Degeneration, Multiple Sclerosis, Oncology (incl. oral solids), Pulmonary Arterial Hypertension, Renal, Rheumatoid arthritis/Chrohn's, Transplant, and Others......66
Table 65: Pharmaceutical Market by Category in Vietnam (2015) - Percentage Share Breakdown by Value for Generic Drugs, Patented Drugs and Others......67
Surgery Market......68
Table 66: Analogic Ultrasound Market for Surgery by Company Worldwide (2014) - Percentage Share Breakdown by Value Sales for Analogic Corporation, GE Medical Systems Ltd., Hitachi-Aloka Medical Ltd., Siemens Corporation, and Others......68
Table 67: General Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 Years, 15-44 Years, 45-64 Years, and 65+ Years......69
Table 68: Surgery Market by Type in the US (2015) - Percentage Share Breakdown by Volume for Bariatric Surgery, Colorectal Surgery, General Surgery, Gynecology/Urology Surgery, and Thoracic Surgery......70
Surgical Procedures......71
Table 69: Surgical Procedures Market by Type in the US (2015) - Percentage Breakdown by Volume for Cardiac, Colon and Rectal, Ears, Nose, and Throat (ENT), General Surgery, Gynecology (GYN), Thoracis and Urology......71
Table 70: Cosmetic Surgical Procedures Market by Category in the US (2015) - Percentage Share Breakdown by Volume for Breast Augmentation, Eyelid Surgery, Facelift, Liposuction, Nose Reshaping, and Others......72
Breast Surgery......73
Table 71: Breast Surgery by Procedures Worldwide (2015) - Percentage Market Share Breakdown by Volume for Breast Augmentation (Augmentation Mammoplasty), Breast Implant Removals (Augmentation Patients Only), Breast Lift (Mastopexy), Breast Reduction (Aesthetic Patients Only), and Breast Reduction in Men (Gynecomastia)......73
Cardiac Surgery......74
Table 72: Cardiac Surgery Market by Segment in the US (2015) - Percentage Share Breakdown by Value Sales for Emergency Room, Home Health, In Patient Hospital, Office Based, Out Patient Hospital, Prescription Drugs......74
Cardiothoracic Surgery......75
Table 73: Cardiothoracic Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for 45-64 Years and 65+ Years......75
Cataract Surgeries......76
Table 74: Cataract Surgeries Market in China (2015-2020) in RMB Million......76
Excimer Surgeries......77
Table 75: Excimer Surgeries Market in China (2015-2020) in RMB Million......77
Table 76: Number of Excimer Surgeries in China (2015-2020) in '000......78
Inpatient Surgery......79
Table 77: Inpatient Surgery Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Cardiovascular, Digestive, Eye, Integumentary, Musculoskeletal, and Others......79
Ophthalmology Surgery......80
Table 78: Ophthalmology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for 45-64 Years, 65+ Years Age, and Others......80
Orthopaedic Surgery......81
Table 79: Orthopaedic Surgery Market by Payer US (2015) - Percentage Share Breakdown by Value for Medicaid, Medicare, Private, Uninsured, and Others......81
Table 80: Orthopedic Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for 15-44 Years, 45-64 Years, and 65+ Years......82
Otolaryngology Surgery......83
Table 81: Otolaryngology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 years, 15-44 Years, 45-64 Years, and 65+ Years......83
Spine Surgery......84
Table 82: Spine Surgery Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Allografts, Anterior Cervical Plate, Anterior Lumbar Interbody Fusion, Anterior Lumbar Plates, Balloon Kyphoplasty, Bone Morphogenetic Proteins, Cervical Artificial Discs, Demineralised Bone Matrix, Intervertebral Spacer Systems, Lumbar Artificial Discs, Post. Pedicle Screw Fusion Systems, Posterior Lumbar Interbody Fusion, Transabd. Lumbar Interbody Fusion, and Vertebroplasty......84
Table 83: Spine Surgery Procedures by Indication in the US (2015) - Percentage Share Breakdown by Volume for Severe Scoliosis, Spondylolisthesis (Lumbar Region), Trauma, and Tumours......85
Urology Surgery......86
Table 84: Urology Surgery by Age Group in the US (2015) - Percentage Market Share Breakdown by No. of Patients for < 15 years, 15-44 Years, 45-64 Years, and 65+ Years......86
Ambulatory Surgery Center......87
Table 85: Ambulatory Surgery Center Market by Speciality Type in the US (2015) - Percentage Share Breakdown by Value Sales for Dermatology, Gastrointestinal, Multispecialty, Ophthalmology, Orthopedics, Pain Management, and Others......87
Surgical Instruments......88
Table 86: Surgical Instruments Market by Category in the US (2015) - Percentage Share Breakdown by Volume Sales for Bariatric Surgery, Colorectal Surgery, General Surgery, GYN, Urology, and Thoracic Surgery......88
Surgical Specialties......89
Table 87: Surgical Specialties Market by Product Segment Worldwide (2015) - Percentage Breakdown by Value for Breast Reconstruction, Gronian Hernia, Hemostatis, Hernia Fixation, Performance of Irrigation, and Ventral Hernia......89
Table 88: Physician Market for Surgical Specialty Sector by Category in the US (2015) - Percentage Share Breakdown by No. of patients for General Surgery, Obstetrics and Gynecology, Ophthalmology, Orthopedic Surgery, Otolaryngology, Urology, and Others......90
Biopharmaceuticals......91
Table 89: Market Shares of Leading Biopharmaceutical Companies Worldwide (2014) - Percentage Breakdown by Volume (Installed Capacity) for Amgen Inc., Biogen Idec, Inc., Bristol-Myers Squibb Company, C.H. Boehringer Sohn AG & Co. KG, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Johnson & Johnson Ltd., Lonza Group Ltd., Pfizer, Inc., Sanofi S.A., and Others......91
Table 90: Market Shares of Leading Biopharmaceutical Companies in the US (2015) - Percentage Market Share Breakdown by Value for Actelion Pharmaceuticals Ltd., Alexion Pharmaceuticals, Inc., Celgene Corporation, Gilead Sciences, Inc., Incyte, Corporation, Isis Pharmaceuticals, Inc., Vertex Pharmaceuticals, Inc., and Others......92
Drugs......93
Table 91: Market Shares of Leading Drug Distributors Worldwide (2014) - Percentage Breakdown by Value for AmerisourceBergen Corporation, Express Scripts, McKesson Corporation, Metro Medical and Others......93
Table 92: Market Shares of Leading Drug Providers in the US (2014) - Percentage Breakdown by Value for Clearwater Paper Corporation and Other Private Label......94
Table 93: Market Shares of Leading Domestic Drugs Manufacturers in Vietnam (2015) - Percentage Share Breakdown by Volume for DHG Pharmaceutical JSC, Traphaco Joint Stock Company and Others......95
Pharmaceuticals......96
Table 94: Market Shares of Leading Pharmaceutical Companies in Australia (2015) - Percentage Share Breakdown by Value for AstraZeneca, Pfizer, Inc. and Others......96
Table 95: Market Shares of Leading Pharmaceutical Distributors in Brazil (2015) - Percentage Share Breakdown by Value for Panpharma Participacoes S.A., Profarma Distribuidora de Produtos Farmaceuticos S.A., Santa Cruz and Others......97
Table 96: Market Shares of Leading Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma Tbk., Pfizer Indonesia PT Tbk, Sanbe Farma PT, and Others......98
Table 97: Market Shares of Leading Pharmaceutical Suppliers to Hospitals in Indonesia (2015) - Percentage Breakdown by Value Sales for Dexa Medica Group, PT Kalbe Farma, Tbk, Sanbe Farma PT, Soho Group, and Others......99
Table 98: Market Shares of Leading Pharmaceutical Drugs Manufacturers in the US (2015) - Percentage Breakdown by Value for Amgen, Eli Lilly and Co., Johnson and Johnson Co, Merck & Co., Inc., Pfizer, Inc., and Others......100
Table 99: Market Shares of Leading Pharmaceutical Manufacturers by Value Sales in the US (2014) - Percentage Breakdown for Abbott Laboratories, Amgen Corporation, AstraZeneca Plc, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck & Co., Inc., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries Ltd., and Others......101
Preclinical Pharmaceuticals......102
Table 100: Market Shares of Leading Preclinical Pharmaceutical Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Charles River Laboratories International, Inc. (CRL), Covance, Inc. (CVD), Pharmaceutical Product Development Inc. (PPDI), Wuxi Pharmatech (Cayman) Inc. (WX), and Others......102
Prescription Pharmaceuticals......103
Table 101: Market Shares of Leading Prescription Pharmaceutical Companies in Indonesia (2015) - Percentage Breakdown by Volume Sales for Dexa Medica Group, Interbat Pharmaceutical Industry PT, PT Kalbe Farma, Tbk, PT Sanbe Farma, and Others......103
Table 102: Market Shares of Leading RX Pharmaceutical Companies in Brazil (2014) - Percentage Breakdown by Value for Achelois Pharmaceuticals, Inc., Eurofarma Laboratórios, Hypermarcas S.A.,Pfizer, Inc., Roche AG, Sanofi - Medley Indústria Farmacêutica Ltda and Others......104
Table 103: Market Shares of Leading Prescription Pharmaceutical Companies in the US (2014) - Percentage Market Share Breakdown by Volume Sales for Actavis Plc, Amneal, Inc., Endo Pharma, Inc., Lupin Pharmaceuticals, Inc., Mylan Labs,Inc., Novartis International AG, Pfizer, Inc., Teva Pharmaceutical Industries Ltd., and Others......105
Table 104: Market Shares of Leading Prescription Drug Companies in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., Teva Pharmaceutical Industries, Ltd., and Others......106
Table 105: Market Shares of Leading Prescription Drug Companies Spending through Media Ads in the US (2014) - Percentage Breakdown by Value for Amgen, AstraZeneca Plc, Eli Lilly and Company, Genentech, Inc., GlaxoSmithKline plc, Johnson & Johnson, Ltd., Novartis International AG, Pfizer, Inc., Sanofi S.A., and Others......107
RadioPharmaceuticals......108
Table 106: Market Shares of Leading Radiopharmaceutical Drug Providers in the US (2015) - Percentage Breakdown by Value for Amersham Plc, Cardinal Health, Inc., Independents, and Triad Healthcare Inc.......108
Table 107: Essex Biotechnology Ltd.’s Sales by Product Segment (2013-2014) in Percentage for Sales of Pharmaceutical Products and Others......109